MedPath

Comparison of the effects of misoprostol and oxytocine on postpartum Hemorrhage

Phase 2
Completed
Conditions
Postpartum hemorrhage.
Other immediate postpartum haemorrhage
072.1
Registration Number
IRCT20100429003833N2
Lead Sponsor
Vice chancellor for Research,Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
237
Inclusion Criteria

singleton pregnant women
elective cesarean delivery
Maximum history of once cesarean section

Exclusion Criteria

Preeclampsia
Cardiovascular diseases
Uterine myoma
A history of excessive bleeding after delivery.
Underlying disease, such as coagulopathy
Abnormal placental implantation (Placenta peria or Ecrta)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding volume during cesarean section. Timepoint: After the placenta is removed until the uterus is repaired. Method of measurement: Number of gases and lumps of wet gases and volume of blood in suction.;Bleeding volume during the first 24 hours of cesarean section. Timepoint: Hemoglobin and hematocrit are measured 24 hours after surgery and compared with preoperative values. Method of measurement: blood test.;Duration of surgery. Timepoint: From the start of surgery to complete repair of the uterus. Method of measurement: Record start and end times.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: From the time of hospitalization to the patient's discharge. Method of measurement: Control vital signs.
© Copyright 2025. All Rights Reserved by MedPath